Bionas and PRIMACYT to Develop Cell-Based Assay to Study Hepatotoxicity | GenomeWeb
NEW YORK (GenomeWeb News) - Bionas and PRIMACYT said today that they will jointly develop a cell-based assay using human liver cells to predict hepatotoxic effects of drugs and chemicals.
 
PRIMACYT, based in Schwerin, Germany, will supply the hepatocytes. The hepatocytes will be cultivated on Bionas metabolic chips with chemically defined media from PRIMACYT.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.